Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
Open Access
- 20 May 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (10) , 3599
Abstract
There has been a great interest in myeloid-derived suppressor cells (MDSCs) due to their biological functions in tumor-mediated immune escape by suppressing antitumor immune responses. These cells arise from altered myelopoiesis in response to the tumor-derived factors. The most recognized function of MDSCs is suppressing anti-tumor immune responses by impairing T cell functions, and these cells are the most important players in cancer dissemination and metastasis. Therefore, understanding the factors and the mechanism of MDSC differentiation, expansion, and recruitment into the tumor microenvironment can lead to its control. However, most of the studies only defined MDSCs with no further characterization of granulocytic and monocytic subsets. In this review, we discuss the mechanisms by which specific MDSC subsets contribute to cancers. A better understanding of MDSC subset development and the specific molecular mechanism is needed to identify treatment targets. The understanding of the specific molecular mechanisms responsible for MDSC accumulation would enable more precise therapeutic targeting of these cells.Keywords
Funding Information
- Sunway University Internal Grant 2020 (GRTIN-RSF-SST-CVVR-01-2020)
This publication has 85 references indexed in Scilit:
- MDSC; the Most Important Cell You Have Never Heard OfTrends in Pharmacological Sciences, 2019
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentTrends in Immunology, 2016
- Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer PatientsJournal of Immunology Research, 2014
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphomaBlood, 2011
- CD49d Is a New Marker for Distinct Myeloid-Derived Suppressor Cell Subpopulations in MiceThe Journal of Immunology, 2010
- Subsets, expansion and activation of myeloid-derived suppressor cellsMedical Microbiology and Immunology, 2010
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing MiceThe Journal of Immunology, 2008
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T CellsGastroenterology, 2008
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activityBlood, 2008